News for Cryoport, Inc. (CYRX)

Cryoport, Inc. (CYRX) reports strong Q1 2025 with 10% revenue growth, strategic DHL partnership, and robust cell & gene therapy advancements.

Cryoport, Inc. (NASDAQ:CYRX) Q1 2025 Results Conference Call May 7, 2025 5:00 PM ETCompany ParticipantsJerrell Shelton - CEORobert Stefanovich - CFOMark...

CryoPort (CYRX) delivered earnings and revenue surprises of 4.35% and 2.91%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

In the latest update from Morgan Stanley, CryoPort (CYRX) has been subject to an adjustment in its target price. On May 5, 2025, analyst Tejas Savant announced

Morgan Stanley has revised its price target for Cryoport (CYRX), reducing it from $8 to $7 while maintaining an Equal Weight rating on the stock. This adjustmen

CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DHL Group (“DHL”), the world’s leading logistics provider, and Cryoport, Inc. (“Cryoport”), a global provider of supply chain solutions for the life

Cryoport, Inc. (NASDAQ:CYRX) Strategic Agreement and Transaction with DHL Group Call March 31, 2025 8:30 AM ETCompany ParticipantsTodd Fromer - Investor...

Germany’s DHL Group is acquiring U.S.-based CryoPDP to boost its health care logistics business. The post DHL to buy US pharma logistics specialist CryoPDP for $195M appeared first on FreightWaves.

U.S. stocks were mixed, with the Nasdaq Composite falling over 1% on Monday. Shares of Mr. Cooper Group Inc. COOP rose sharply during Monday's session after th...

CryoPort (CYRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

PR NewswireNASHVILLE, Tenn., March 12, 2025 NASHVILLE, Tenn., March 12, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a

Release Date: March 04, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points CryoPort Inc (C

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NCYRX.OQ - Cryoport IncQ4 2024 Cryoport Inc Earnings CallMar 04, 2025 / 10:00PM GMT ===========

The following slide deck was published by Cryoport, Inc.

Start Time: 17:00 January 1, 0000 5:41 PM ETCryoport, Inc.

Quarterly Revenue: Achieved $59.5 million in Q4 2024, surpassing the estimated revenue of $58.55 million.Annual Revenue: Reported $228.4 million for FY 2024, a

CryoPort (CYRX) delivered earnings and revenue surprises of -27.27% and 0.46%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

PR NewswireNASHVILLE, Tenn., March 4, 2025 FY 2024 revenue of $228.4 million, in-line with company guidanceCommercial Cell & Gene Therapy revenue rose to $